Study design and rationale for ELPIS: A phase I/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome

Overview of attention for article published in American Heart Journal, June 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 2 X users

patent: 6 patents

Readers on

mendeley: 93 Mendeley

So far, Altmetric has seen 6 patents that reference this research output.

MESENCHYMAL LINEAGE PRECURSOR OR STEM CELLS (MLPSCS) FOR USE IN METHODS OF TREATING…

Application WO-2025062365-A1

World Intellectual Property Organisation (WIPO)

27 Mar 2025

Cardiac stem cells for cardiac repair

Grant US-12220432-B2

United States of America

11 Feb 2025

Cardiac stem cells for cardiac repair

Grant US-12156891-B2

United States of America

03 Dec 2024

Cardiac stem cells for cardiac repair

Grant US-12064454-B2

United States of America

20 Aug 2024

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 2 additional patents.